Skip to main content
Contra Costa County Header
File #: 25-5303    Version: 1 Name:
Type: Consent Item Status: Agenda Ready
File created: 11/13/2025 In control: BOARD OF SUPERVISORS
On agenda: 12/16/2025 Final action:
Title: APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with Sanofi Pasteur Inc., in an amount not to exceed $650,000 for the purchase of vaccines and injectable medications for the Contra Costa Regional Medical Center and Contra Costa Health Centers for the period January 1, 2026 through December 31, 2026. (100% Hospital Enterprise Fund I)
Date Ver.Action ByActionResultTallyAction DetailsMeeting DetailsVideo
No records to display.
To: Board of Supervisors
From: Dr. Grant Colfax, Health Services Director
Report Title: Purchase Order with Sanofi Pasteur, Inc.
?Recommendation of the County Administrator ? Recommendation of Board Committee


RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with Sanofi Pasteur Inc., in an amount not to exceed $650,000 for the purchase of vaccines and injectable medications for the Contra Costa Regional Medical Center (CCRMC) and Contra Costa Health Centers, for the period from January 1, 2026 through December 31, 2026.

FISCAL IMPACT:
Approval of this action will result in expenditures of up to $650,000 and will be funded by Hospital Enterprise Fund I revenues.

BACKGROUND:
Sanofi Pasteur Inc. furnishes pharmaceuticals for patient care provided in the hospital and clinics. These vaccines and other injectable medications are essential for patient care. Sanofi is the maker of critical injectables for the hospital including Insulin for Type I and Type II diabetic patients, vaccines, and different immune globulin formulations including Intravenous Immune Globulin (IVIG), a life-saving medication used to treat primary immunodeficiency to reduce the risk of infection in individuals with poorly functioning immune systems. IVIG is also used to increase platelets (blood clotting cells) in people with idiopathic thrombocytopenic purpura (ITP) and to prevent aneurysms caused by a weakening of the main artery in the heart associated with Kawasaki syndrome.

On October 21, 2025 the Board of Supervisors approved agenda item C.53 to execute an amendment to purchase order #31625 with Sanofi Pasteur Inc., to increase the payment limit by $150,000 to a new amount not to exceed $725,000 for the purchase of vaccines and injectable medications at CCRMC and Health Centers, with no change in the original term of January 1, 2025 through December 31, 2025. On November 25, 2025, the Purchasing...

Click here for full text